INVESTOR LOGIN

LRG BayStar Capital Funds Portfolio

PORTFOLIO COMPANIES

Please find some the portfolio of current and prior LRG BayStar Capital Funds' portfolio companies below:

Duramed Pharmaceuticals, Inc. (DRMD)

Duramed Pharmaceuticals, Inc. (DRMD)

Duramed Pharmaceutical, Now a subsidiary of Barr Pharmaceuticals develops, manufactures, and markets prescription drug products focusing primarily on solid oral dose hormone replacement therapy (HRT) products.
 

Ligand Pharmaceuticals, Inc. (LGND)

Ligand Pharmaceuticals, Inc. (LGND)

Ligand discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, skin diseases, and men¹s and women¹s hormone related diseases, as well as osteoporosis, metabolic disorders and cardiovascular and inflammatory diseases. http://www.ligand.com

NeoRx Corporation

NeoRx Corporation

NeoRx Corporation, now Poniard Pharmaceuticals, is a cancer therapeutic product development company with technologies for targeted delivery of therapeutic agents, including radiopharmaceuticals, to tumor sites.
 
 

Penwest Pharmaceuticals Company (PPCO)

Penwest Pharmaceuticals Company (PPCO)

Penwest Pharmaceuticals Company is engaged in the research, development and commercialization of innovative oral drug delivery technologies and products to the global pharmaceutical industry.
  http://www.penw.com

Salix Pharmaceuticals, Ltd. (SLXP)

Salix Pharmaceuticals, Ltd. (SLXP)

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes late-stage pharmaceutical products used in the treatment of a variety of gastrointestinal diseases.
 
  http://www.salix.com

 
Arque Capital
This website is for general informational purposes only and is not intended as a solicitation or offering for any investment product or service.
LRG Capital Group, in alliance with Arque Capital, Ltd. Member FINRA/SIPC